Table 4.
Characteristics of 8 patients with changes in causality scores from a 4 to a 3 or a 3 to a 4 after liver biopsy review.
| Age years | Sex | Injury | Implicated Drug | Time to biopsy [days] | Pre-Bx score | Post-Bx score | Peak ALT [U/L] | Peak Alk P [U/L] | Peak T bili [mg/dL] | Viral serology | AI serology | Imaging | Histological Findings and comment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85 | F | HC | Levofloxacin | 2 | 4 | 3 | 980 | 120 | 3.2 | HCV RNA Pos | Pos | Neg | Chronic cholestasis and acute hepatitis superimposed on underlying chronic viral hepatitis and NASH. Despite two preexisting liver diseases, the pathology cannot be explained by either. Fluoroquinolones have been associated with both acute hepatitis and cholestatic injury patterns. |
| 67 | M | Chol | Voriconazole | 7 | 4 | 3 | 606 | 1310 | 9.7 | Neg | NA | Neg | Acute cholestasis and necrosis superimposed on HSCT-associated NRH and obliterative portal venopathy. Other cause of cholestasis excluded by history and azole antifungals are associated with both acute hepatitis and cholestatic injury patterns. |
| 48 | F | Chol | Azithromycin | 12 | 4 | 3 | 239 | 1406 | 5.3 | Neg | Neg | Neg | Changes of chronic cholestasis superimposed on HSCT or AML-associated NRH and obliterative portal venopathy. Although the cholestatic findings are subtle, they coincide with the clinical picture cholestatic injury and azithromycin is known to cause chronic cholestatic injury. |
| 62 | M | HC | Amiodarone | 29 | 4 | 3 | 781 | 168 | 7.7 | Neg | Pos | Bil dil | Cirrhosis with numerous Mallory-Denk bodies and mild steatosis. The injury is typical for cirrhosis related to amiodarone. |
| 52 | M | Chol | Cefuroxime | 28 | 4 | 3 | 268 | 651 | 8.4 | Neg | Neg | Neg | Chronic cholestasis with zone 3 necrosis, no changes to suggest PBC or PSC. Unusual combination injury favors DILI and cephalosporins are associated with cholestatic injury patterns. |
| 26 | F | HC | Infliximab | 25 | 4 | 3 | 2894 | 200 | 4.4 | Neg | Neg | Neg | Acute hepatitis with prominent plasma cell infiltrates. Infliximab is associated with AIH-like pathology and the autoimmune serologies were negative. |
| 46 | F | Chol | Amoxicillin | 9 | 3 | 4 | 450 | 723 | 25.7 | Neg | Pos | Neg | Acute hepatitis with diffuse parenchymal injury, venulitis, no cholestasis. Atypical for amoxicillin, which typically shows cholestatic hepatitis. |
Abbreviations: F, female; M, male; HC, hepatocellular; Chol, cholestatic; Bx, biopsy; HCV, hepatitis C virus, NA, not available; Bil dil, biliary dilatation; AIH, autoimmune hepatitis; HSCT, hematopoietic stem cell transplant; NRH, nodular regenerative hyperplasia; AML, acute myelogenous leukemia; PBC, primary biliary cholangitis; PSC, primary biliary sclerosis.